Home > PS Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of TORRENT PHARMACEUTICALS is 9.74.

Share Price ₹3,313.2Jul 11,2025
Market Cap ₹112,117.0 Cr
Sales-TTM₹11,516.0 CrTTM-Consolidated Results
Price/Sales9.74xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹112,117.0 Cr] as on Jul 11,2025

(/) Sales [ ₹11,516.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 9.74x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '9.74 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS


PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/e ratio is 9.74x.

- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.81x.

- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 5.56x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 9.51x.

- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 5.37x.


How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
TORRENT PHARMACEUTICALS 11,516.09.74112,117.0
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.63401,289.0
DIVIS LABORATORIES LTD9,360.019.38181,397.0
CIPLA LTD27,547.64.35119,955.0
DR REDDYS LABORATORIES LTD32,643.93.21104,657.0
MANKIND PHARMA LTD12,279.38.67106,401.0
ZYDUS LIFESCIENCES LTD23,241.54.2498,570.7
LUPIN LTD22,707.93.8186,442.7
AUROBINDO PHARMA LTD31,723.72.0665,308.2
ABBOTT INDIA LTD6,409.211.4173,118.7
ALKEM LABORATORIES LTD12,964.54.4357,474.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.06x
Max industry PS 19.38x
Median industry PS 4.43x
Average industry PS 7.18x



You may also like the below Video Courses